1. OPUS at UTS

Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
2022-10-19Association of KCNJ6 rs2070995 and methadone response for pain management in advanced cancer at end-of-life.Ozberk, D; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Zunk, M; George, R; Good, P; Griffiths, LR; Hardy, J; Haupt, LM
2021-09Professionals', patients' and families' views on the use of opioids for chronic breathlessness: A systematic review using the framework method and pillar process.Reedy, F; Pearson, M; Greenley, S; Clark, J; Currow, DC; Bajwah, S; Fallon, M; Johnson, MJ
2017-02A Case of Opioid Toxicity on Conversion From Extended-Release Oxycodone and Naloxone to Extended-Release Oxycodone in a Patient With Liver Dysfunction.Franklin, AE; Lovell, MR; Boyle, F
2022-07A systematic review of assessment approaches to predict opioid misuse in people with cancer.Keall, R; Keall, P; Kiani, C; Luckett, T; McNeill, R; Lovell, M
2017-09Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?George, R; Haywood, A; Good, P; Hennig, S; Khan, S; Norris, R; Hardy, J
2017-02An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer.Pinkerton, E; Good, P; Gibbons, K; Hardy, J
2022-01-01Opioid-sparing effects of ketorolac in palliative care patients receiving opioids for chronic cancer-related pain: A systematic literature review.Butcher, B; Hutchings, E; Fazekas, B; Clark, K; Rowett, D; Currow, D
2022-04Association of polymorphisms in ARRB2 and clinical response to methadone for pain in advanced cancer.Ozberk, D; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Zunk, M; George, R; Good, P; Griffiths, LR; Hardy, J; Haupt, LM
2023-07Does cancer type and adjuvant analgesic prescribing influence opioid dose?-a retrospective cross-sectional study.Wong, AK; Hawke, J; Eastman, P; Buizen, L; Le, B
2023-03-01Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD).Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P
Results 1-10 of 21 (Search time: 0.015 seconds).

Discover